The choroid plexus removes β-amyloid from brain cerebrospinal fluid

Experimental Biology and Medicine

Volumn 230, Issue 10, 2005, Pages 771-776

  Crossgrove, Janelle S ^a   Li, G Jane ^a   Zheng, Wei ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cerebrospinal fluid; Choroid plexus; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E3; PREALBUMIN; SUCROSE;

ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CEREBROSPINAL FLUID; CHOROID; CONTROLLED STUDY; DISEASE COURSE; EFFUSION; EPITHELIUM CELL; MALE; NONHUMAN; RAT; TEMPERATURE DEPENDENCE;

EID: 27644457417     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523001011     Document Type: Article

References (25)

1. Goldgaber D, Schwarzman AI, Bhasin R, Gregori L, Schmechel D, Saunders AM, Roses AD, Strittmatter WJ. Sequestration of amyloid beta-peptide. Ann N Y Acad Sci 695:139-143, 1993.
2. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29:106-117, 2003.
3. Zlokovic BV. Clearing amyloid through the blood-brain barrier. J Neurochem 89:807-811, 2004.
4. Zheng W, Aschner M, Ghersi-Egea JF. Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192:1-11, 2003.
5. Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol 44:17-26, 1998.
6. Tapiola T, Pirttila T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, Soininen H. Three-year follow-up of cerebrospinal fluid tau, betaamyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci Lett 280:119-122, 2000.
7. Eriksson L, Westermark P. Characterization of intracellular amyloid fibrils in the human choroid plexus epithelial cells. Acta Neuropathol (Berl) 80:597-603, 1990.
8. Zheng W, Zhao Q. The blood-CSF barrier in culture. Development of a primary culture and transepithelial transport model from choroidal epithelial cells. Methods Mol Biol 188:99-114, 2002.
9. Teuscher NS, Shen H, Shu C, Xiang J, Keep RF, Smith DE. Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. J Neurochem 89:375-382, 2004.
10. Welch K. Active transport of iodide by choroid plexus of the rabbit in vitro. Am J Physiol 202:757-760, 1962.
11. Dziegielewska KM, Evans CA, Malinowska DH, Mollgard K, Reynolds JM, Reynolds ML, Saunders NR. Studies of the development of brain barrier systems to lipid insoluble molecules in fetal sheep. J Physiol 292:207-231, 1979.
12. Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, Yan SD, Stern D, Schmidt AM, Frangione B, Zlokovic BV. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102:734-743, 1998.
13. Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD. Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 67:880-883, 1996.
14. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, Zagorski MJ, Talafous J, Eisenberg M, Saunders AM, Roses AD, Goldgaber D. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A 91:8368-8372, 1994.
15. Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 258:R338-R345, 1990.
16. Lignelid H, Collins VP, Jacobsson B. Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol (Berl) 93:494-500, 1997.
17. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem 69:1995-2004, 1997.
18. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699, 1993.
19. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981, 1993.
20. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907-913, 2003.
21. Bush AI. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging 23:1031-1038, 2002.
22. Strazielle N, Ghersi-Egea JF. Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19:6275-6289, 1999.
23. Gorman PM, Chakrabartty A. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products. Biopolymers 60:381-394, 2001.
24. Dumery L, Bourdel F, Soussan Y, Fialkowsky A, Viale S, Nicolas P, Reboud-Ravaux M. beta-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease. Pathol Biol (Paris) 49:72-85, 2001.
25. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298, 2003.